These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7524315)

  • 21. The molecular basis of nephrogenic diabetes insipidus.
    Oksche A; Rosenthal W
    J Mol Med (Berl); 1998 Apr; 76(5):326-37. PubMed ID: 9587067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of aquaporins: a breakthrough in research on renal water transport.
    van Lieburg AF; Knoers NV; Deen PM
    Pediatr Nephrol; 1995 Apr; 9(2):228-34. PubMed ID: 7540850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary content of aquaporin 1 and 2 in nephrogenic diabetes insipidus.
    Deen PM; van Aubel RA; van Lieburg AF; van Os CH
    J Am Soc Nephrol; 1996 Jun; 7(6):836-41. PubMed ID: 8793791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and cellular defects in nephrogenic diabetes insipidus.
    Knoers NV; van Os CH
    Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):353-8. PubMed ID: 8823534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasopressin type-2 receptor and aquaporin-2 water channel mutants in nephrogenic diabetes insipidus.
    Deen PM; Knoers NV
    Am J Med Sci; 1998 Nov; 316(5):300-9. PubMed ID: 9822112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normal fibrinolytic responses to 1-desamino-8-D-arginine vasopressin in patients with nephrogenic diabetes insipidus caused by mutations in the aquaporin 2 gene.
    van Lieburg AF; Knoers VV; Mallmann R; Proesmans W; van den Heuvel LP; Monnens LA
    Nephron; 1996; 72(4):544-6. PubMed ID: 8730418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal mortality in an aquaporin-2 knock-in mouse model of recessive nephrogenic diabetes insipidus.
    Yang B; Gillespie A; Carlson EJ; Epstein CJ; Verkman AS
    J Biol Chem; 2001 Jan; 276(4):2775-9. PubMed ID: 11035038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of an aquaporin-2 water channel gene mutation causing partial nephrogenic diabetes insipidus in a Mexican family: evidence of increased frequency of the mutation in the town of origin.
    Boccalandro C; De Mattia F; Guo DC; Xue L; Orlander P; King TM; Gupta P; Deen PM; Lavis VR; Milewicz DM
    J Am Soc Nephrol; 2004 May; 15(5):1223-31. PubMed ID: 15100362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. cDNA and genomic cloning of mouse aquaporin-2: functional analysis of an orthologous mutant causing nephrogenic diabetes insipidus.
    Yang B; Ma T; Xu Z; Verkman AS
    Genomics; 1999 Apr; 57(1):79-83. PubMed ID: 10191086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of aquaporin-2 expression levels in genotype -phenotype studies in nephrogenic diabetes insipidus.
    Kamsteeg EJ; Deen PM
    Am J Physiol Renal Physiol; 2000 Oct; 279(4):F778-84. PubMed ID: 10997928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functionality of aquaporin-2 missense mutants in recessive nephrogenic diabetes insipidus.
    Marr N; Kamsteeg EJ; van Raak M; van Os CH; Deen PM
    Pflugers Arch; 2001 Apr; 442(1):73-7. PubMed ID: 11374071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine.
    Deen PM; Verdijk MA; Knoers NV; Wieringa B; Monnens LA; van Os CH; van Oost BA
    Science; 1994 Apr; 264(5155):92-5. PubMed ID: 8140421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analyses of the vasopressin type 2 receptor and aquaporin-2 genes in Brazilian kindreds with nephrogenic diabetes insipidus.
    Rocha JL; Friedman E; Boson W; Moreira A; Figueiredo B; Liberman B; de Lacerda L; Sandrini R; Graf H; Martins S; Puñales MK; De Marco L
    Hum Mutat; 1999; 14(3):233-9. PubMed ID: 10477431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of aquaporin-2 in the plasma membranes of oocytes: a novel isolation method with improved yield and purity.
    Kamsteeg EJ; Deen PM
    Biochem Biophys Res Commun; 2001 Apr; 282(3):683-90. PubMed ID: 11401515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autosomal recessive nephrogenic diabetes insipidus caused by an aquaporin-2 mutation.
    Hochberg Z; Van Lieburg A; Even L; Brenner B; Lanir N; Van Oost BA; Knoers NV
    J Clin Endocrinol Metab; 1997 Feb; 82(2):686-9. PubMed ID: 9024277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of an aquaporin-2 mutation causing a severe form of nephrogenic diabetes insipidus.
    Saglar Ozer E; Moeller HB; Karaduman T; Fenton RA; Mergen H
    Cell Mol Life Sci; 2020 Mar; 77(5):953-962. PubMed ID: 31302751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families.
    Pasel K; Schulz A; Timmermann K; Linnemann K; Hoeltzenbein M; Jääskeläinen J; Grüters A; Filler G; Schöneberg T
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1703-10. PubMed ID: 10770218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus].
    Knoers NV; Deen PM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2402-4. PubMed ID: 11145096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of nephrogenic diabetes insipidus by aquaporin-2 C-terminus mutations.
    Asai T; Kuwahara M; Kurihara H; Sakai T; Terada Y; Marumo F; Sasaki S
    Kidney Int; 2003 Jul; 64(1):2-10. PubMed ID: 12787389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further evidence for functional recovery of AQP2 mutations associated with nephrogenic diabetes insipidus.
    Bissonnette P; Lussier Y; Matar J; Leduc-Nadeau A; Da Cal S; Arthus MF; Unwin RJ; Steinke J; Rangaswamy D; Bichet DG
    Physiol Rep; 2021 Jun; 9(11):e14866. PubMed ID: 34120413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.